The health economic implications of treatment with quetiapine: an audit of long-term treatment for patients with chronic schizophrenia

By Lynch J.   Morrison J.   Graves N.   Meddis D.   Drummond M.F.   Hellewell J.S.E.  

European Psychiatry, Vol. 16, Iss. 5, 2001-08 ,pp. : 307-312

Elsevier

Access to resources Recommend Favorite

Long-term efficacy and safety of quetiapine in treatment-refractory schizophrenia: A case report

By Reznik I   Benatov R   Sirota P  

International Journal of Psychiatry in Clinical Practice, Vol. 4, Iss. 1, 2000-03 ,pp. : 77-80

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The long-term effect of quetiapine (Seroquel^TM) monotherapy on weight in patients with schizophrenia

By Brecher M   Rak I.W.   Melvin K   Jones A.M.  

International Journal of Psychiatry in Clinical Practice, Vol. 4, Iss. 4, 2000-12 ,pp. : 287-291

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The "Seroquel" Outcomes Study (SOS): Efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia

By Gibert Juan   Giner José   Bobes Julio   Tafalla Mónica   Herranz Santiago   Ovejero Carmen   Rico-Villademoros Fernando   GROUP for the SOS  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 3, 2007-01 ,pp. : 222-232

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study

By Lee Phil   Eung Kim Chul   Yoon Kim Chang   Lin Wei-Wen   Habil Hussain   Dyachkova Yulia   Mcbride Margaret   Dossenbach Martin  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 215-227

Ashgate Publishing Ltd

Access to resources Recommend Favorite